Merck's Licensing & External Research Director Jennifer Hu On Choosing Partners In China: An Interview With PharmAsia News

Big pharma's rush into emerging markets is bringing more R&D to these markets, and as one of the key emerging markets China has attracted most multinational companies to set their R&D and licensing footprint here. Jennifer Hu, Merck's director of licensing and external research, recently shared her thoughts with PharmAsia News' Shanghai bureau about Merck's partnering and licensing strategy in China.